跳至主要内容
临床试验/NCT01794884
NCT01794884已完成2 期

Intravenous Supplementation of Glutamine Preoperatively for Cardiac Function and Recovery Improvement in Adult Accepting Cardiosurgery: A Randomized, Double-Blinded, Placebo-Controlled Trial

Yuejiang Liu1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
33
试验地点
1
主要终点
perioperative changes of Cardiac Index (CI)

研究概览

简要总结

In view of the lack of large-scale clinical study and potent evidence-based medicine, the investigators designed a randomized, double-blind, placebo-controlled study to ascertain whether preoperative intravenous administration with glutamine can improve the postoperative cardiac function and prognosis of adult patients undergoing cardiac surgery. The investigators want to detect the levels of myocardial protein O-GlcNAc modification and HSP70 expression, changes in sensitive indicators of myocardial injury, systemic inflammatory reaction and oxidative stress levels, and to examine the correlation between these changes and Clinical manifestations. The ultimate goal of the study is to explore a new way for clinical myocardial protection.

详细描述

Cardiosurgery is mostly done under cardiopulmonary bypass. However, the cardiopulmonary bypass and the later recovery of spontaneous circulation, a cardiac ischemia / reperfusion process, may cause myocardial damage and affect cardiac function as well as prognosis.

Glutamine, an amino acid abundant in the human body, plays an important role in the regulation of metabolism and immune cells and the protection of organs. Relative lack of glutamine is reported during stress or serious illness. Animal studies have confirmed that pretreatment with glutamine has a protective effect on the heart, liver, kidney and other organs post ischemia / reperfusion injury. It is also established that glutamine exerts myocardial protection mainly by activating hexosamine biosynthetic pathway, increasing intracellular O-GlcNAc protein modification and expression of heat shock protein 70 (HSP70), starting the protective reaction in the body, improving the function of myocardial cells, and inhibiting the release of inflammatory cytokines and oxidative stress levels. Besides, clinical studies have shown that at the perioperative stage glutamine has a protective effect on cardiac function of the patients treated with pump coronary artery bypass surgery.

The purpose of this study is to ascertain whether preoperative intravenous administration with glutamine (as compared with control group) can improve the postoperative cardiac function and prognosis of adult patients undergoing cardiac surgery and reduce inflammatory response and oxidative stress levels of the body. The correlation between Clinical manifestations and expression of myocardium O-GlcNAc and HSP70 will also be investigated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with coronary artery disease or rheumatic heart disease accepted cardiosurgery under cardiopulmonary bypass

排除标准

  • ejection fraction(EF)<50%
  • Preoperative support with intra-aortic balloon pump(IABP)
  • Hepatosis
  • Renal dysfunction
  • Myocardial infarction attack within 3 months
  • Emergency operation

研究组 & 干预措施

Glutamine

Experimental

20% N(2)-L-alanyl-L-glutamine 0.4g/kg(2ml/kg) mixed with compound amino acid (10ml/kg)(volume ratio=1:5).Intravenous injection twice (24 hours、1 hour before operation).

干预措施: Glutamine (Drug)

Ringer's solution

Placebo Comparator

Ringer's solution 12ml/kg. Intravenous injection twice (24 hours、1 hour before operation).

干预措施: Ringer's solution (Drug)

结局指标

主要结局

perioperative changes of Cardiac Index (CI)

时间窗: postanescesia before surgery, 2, 20 hours after cardiopulmonary bypass (CPB)

For each patient,a Swan-Ganz catheter will be inserted after anesthesia induction.CI and other values of hemodynamics will be measured.

次要结局

  • Troponin I(cTnI)(postanescesia before surgery, 6, 20 hours after CPB)
  • Brain Natriuretic Peptide (BNP)(postanescesia before surgery, 6, 20 hours after CPB)
  • Systemic inflammation(postanescesia before surgery, 2, 20 hours after CPB)
  • Heart issue HSP-70(20 minutes after CPB)
  • Heart issue O-GlcNAc(20 minutes after CPB)
  • Recovery index(Date of surgery until date of hospital discharge (an expected average of 2 weeks))

研究者

发起方
Yuejiang Liu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yuejiang Liu

Associate Professor

Southeast University, China

研究点 (1)

Loading locations...

相似试验

Validity Study of Glutamine to Improve Cardiac... | 临床试验